A 36-year-old female liver transplant recipient developed liver decompensation during peginterferon-alpha/ribavirin therapy for recurrent hepatitis C virus infection.
A 36-year-old female liver transplant recipient developed liver decompensation during peginterferon-alpha/ribavirin therapy for recurrent hepatitis C virus infection.
1例36岁接受肝移植的妇女在使用长效干扰素和利巴韦林治疗复发性丙型肝炎病毒感染时发生肝功能衰竭。